Innate and adaptive immune responses to an intracellular bacterium, Francisella tularensis live vaccine strain.
about
Differential effects of type I and II interferons on myeloid cells and resistance to intracellular bacterial infectionsThe involvement of IL-17A in the murine response to sub-lethal inhalational infection with Francisella tularensisEvasion of IFN-γ signaling by Francisella novicida is dependent upon Francisella outer membrane protein CNasal Acai polysaccharides potentiate innate immunity to protect against pulmonary Francisella tularensis and Burkholderia pseudomallei InfectionsPolysaccharides isolated from Açaí fruit induce innate immune responsesNovel catanionic surfactant vesicle vaccines protect against Francisella tularensis LVS and confer significant partial protection against F. tularensis Schu S4 strainThe reduced genome of the Francisella tularensis live vaccine strain (LVS) encodes two iron acquisition systems essential for optimal growth and virulenceRole of TLR signaling in Francisella tularensis-LPS-induced, antibody-mediated protection against Francisella tularensis challenge.The fslE homolog, FTL_0439 (fupA/B), mediates siderophore-dependent iron uptake in Francisella tularensis LVS.Modulation of hepatic PPAR expression during Ft LVS LPS-induced protection from Francisella tularensis LVS infection.CXCR3 and its ligands participate in the host response to Bordetella bronchiseptica infection of the mouse respiratory tract but are not required for clearance of bacteria from the lungIntranasal interleukin-12 treatment for protection against respiratory infection with the Francisella tularensis live vaccine strain.Identification of T-cell epitopes in Francisella tularensis using an ordered protein array of serological targets.Enhancement of vaccine efficacy by expression of a TLR5 ligand in the defined live attenuated Francisella tularensis subsp. novicida strain U112ΔiglB::fljB.Development of functional and molecular correlates of vaccine-induced protection for a model intracellular pathogen, F. tularensis LVS.Visualization of murine intranasal dosing efficiency using luminescent Francisella tularensis: effect of instillation volume and form of anesthesia.IL-23 p19 knockout mice exhibit minimal defects in responses to primary and secondary infection with Francisella tularensis LVSMucosal immunization with live attenuated Francisella novicida U112ΔiglB protects against pulmonary F. tularensis SCHU S4 in the Fischer 344 rat modelIntranasal vaccination with a defined attenuated Francisella novicida strain induces gamma interferon-dependent antibody-mediated protection against tularemia.A mucosal subunit vaccine protects against lethal respiratory infection with Francisella tularensis LVS.Genetic identification of unique immunological responses in mice infected with virulent and attenuated Francisella tularensisGlycogen synthase kinase-3beta (GSK3beta) inhibition suppresses the inflammatory response to Francisella infection and protects against tularemia in miceToll-like receptor 2 is required for inflammatory responses to Francisella tularensis LVSIdentification of Francisella tularensis genes affected by iron limitation.Tularemia: current diagnosis and treatment options.Low dose aerosol infection of mice with virulent type A Francisella tularensis induces severe thymus atrophy and CD4+CD8+ thymocyte depletion.The francisella tularensis proteome and its recognition by antibodies.Role of mTOR downstream effector signaling molecules in Francisella tularensis internalization by murine macrophages.Tryptophan prototrophy contributes to Francisella tularensis evasion of gamma interferon-mediated host defense.Non-FcεR bearing mast cells secrete sufficient interleukin-4 to control Francisella tularensis replication within macrophagesA Francisella tularensis locus required for spermine responsiveness is necessary for virulence.Immunoproteomic analysis of the human antibody response to natural tularemia infection with Type A or Type B strains or LVS vaccinationDefensive applications of gene transfer technology in the face of bioterrorism: DNA-based vaccines and immune targeting.Characterization of Francisella tularensis outer membrane proteins.Targeting of a Fixed Bacterial Immunogen to Fc Receptors Reverses the Anti-Inflammatory Properties of the Gram-Negative Bacterium, Francisella tularensis, during the Early Stages of InfectionMouse model of oral infection with virulent type A Francisella tularensis.Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion.Virulence comparison in mice of distinct isolates of type A Francisella tularensis.Role of primary human alveolar epithelial cells in host defense against Francisella tularensis infection.Toll-like receptor 2-mediated signaling requirements for Francisella tularensis live vaccine strain infection of murine macrophages
P2860
Q26849516-3B5EF880-9077-4391-962E-5565F2DC9A7DQ27324829-E1F76C35-65AD-471E-8761-8B42553C5EC0Q28477609-73C4F0EC-7913-4381-8DF0-6537CF438FE3Q28731282-6354C921-59EB-4186-B3C4-24CEA6EA143EQ28742327-46FC5AC8-4FB3-44B7-A54C-1E6545A632B8Q30411506-F0DB5BAC-996E-485D-91C2-5FD8AC984056Q30413938-4F667B5D-DD2E-4955-91B1-13CF4F6E6B1BQ30424747-D8452B57-3D50-4C2B-B3A1-FF70B791E68DQ30432826-BB866BF2-1797-4E00-9A12-AB20633C7B24Q33524893-821E2206-83AA-4A81-9FDF-5DB38D4AE972Q33556867-7C4FBD8E-87CE-4884-A666-36AEB7204582Q33769426-3C85091E-1748-4BC6-8140-F951216A9F11Q33788322-57948856-53CC-4479-A9DA-8EEEE2CFB032Q34074366-61E6E1F3-A48E-4A92-9DAE-7D9CC3ADABEFQ34139968-132D3593-F7DA-4F4A-AB97-00C1B101E4FFQ34181668-4105008B-CA9C-4770-91D1-0BDED9C30728Q34309279-CE9A7085-B45F-41B3-8263-EC7C354247FDQ34464553-EFDC5BDE-B643-44E2-BC7A-84B6C6B73EBAQ34492667-23B8A922-13AC-43BC-88F5-264663E8037DQ34500312-DDC5850F-A4AF-4297-812C-009AD6596E7EQ34543138-54E7AF8A-EB09-412B-8B96-16519D94583CQ34552307-602DBE02-4366-48B0-9A16-76873DD3385AQ34601931-8E9B8786-4D33-4980-B744-6CBC025867E6Q34721354-12FC46CD-33DB-4A49-8A95-660EFFCE3CCDQ34766440-01F18270-CD47-4AF3-9DC3-975FB54D38EDQ35025586-767A37E9-0C72-484A-AF9E-306A260B3081Q35029271-7A0F8B96-03AC-4BAF-AEE6-DED47C1C2135Q35061591-160049E8-3233-4D4E-B282-3DBC9FEBE26FQ35075784-1F9EC9FF-CBF9-49DD-BD48-AD310F924AD2Q35163979-2325F7F5-F3A0-4300-B319-0872CCA7BBB6Q35191938-93BE5094-52A1-42EF-81C3-89F6CC4972EFQ35251703-176ABF45-F4A7-4A35-AEFD-51A768078FC3Q35594090-E8549441-19A4-44ED-9583-AC996F6BE50AQ35634834-214BF310-E0DB-47E1-B91C-C52533F8B7EBQ35675388-0946B56A-113C-4581-B8EC-7063BDDB9A13Q35783736-FE7D3758-77F4-4160-A154-08E9D207ADE5Q35784151-EDB0B39C-D569-4FEB-807B-FF37F41FE3C7Q35792914-89445913-3519-4676-8974-F955AABA816EQ35949657-B4E01364-96B7-4F35-BD60-7B723B10BEE2Q35949677-A02FB39A-AB22-4684-A63F-32A7DE2699B2
P2860
Innate and adaptive immune responses to an intracellular bacterium, Francisella tularensis live vaccine strain.
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Innate and adaptive immune res ...... ularensis live vaccine strain.
@ast
Innate and adaptive immune res ...... ularensis live vaccine strain.
@en
type
label
Innate and adaptive immune res ...... ularensis live vaccine strain.
@ast
Innate and adaptive immune res ...... ularensis live vaccine strain.
@en
prefLabel
Innate and adaptive immune res ...... ularensis live vaccine strain.
@ast
Innate and adaptive immune res ...... ularensis live vaccine strain.
@en
P2093
P1476
Innate and adaptive immune res ...... ularensis live vaccine strain.
@en
P2093
Catharine M Bosio
Karen L Elkins
Siobhán C Cowley
P304
P356
10.1016/S1286-4579(02)00084-9
P577
2003-02-01T00:00:00Z